RLAY
Relay Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RLAY fundamentals
Relay Therapeutics (RLAY) released its earnings on Nov 6, 2025: revenue was 0 (YoY 0.00%), missed estimates; EPS was -0.43 (YoY +31.75%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.43
+31.75%
Report date
Nov 6, 2025
Earnings Call
4:05 PM on Nov 6, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Relay Therapeutics (RLAY) key financial stats and ratios, covering profitability, financial health, and leverage.
Relay Therapeutics (RLAY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Relay Therapeutics (RLAY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Relay Therapeutics (RLAY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Relay Therapeutics (RLAY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Relay Therapeutics (RLAY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Relay Therapeutics's management provide for the next earnings period?Did Relay Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Relay Therapeutics next quarter?What were the key takeaways from Relay Therapeutics’s earnings call?What is Relay Therapeutics's gross profit margin?What were the key takeaways from Relay Therapeutics's earnings call?What is Relay Therapeutics's latest dividend and current dividend yield?What does Relay Therapeutics do and what are its main business segments?
